Infiltration of M2-polarized macrophages in infected lymphatic malformations: possible role in disease progression

British Journal of Dermatology

Volumn 175, Issue 1, 2016, Pages 102-112

  Zhang, W ^a   He, K F ^a   Yang, J G ^a   Ren, J G ^a   Sun, Y F ^a   Zhao, J H ^a   Zhao, Y F ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADDRESSIN; ANTIBODY; CD20 ANTIGEN; CD3 ANTIGEN; CD68 ANTIGEN; COLONY STIMULATING FACTOR 1; KI 67 ANTIGEN; LIPOPOLYSACCHARIDE; VASCULOTROPIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE COURSE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INFECTION; LYMPHATIC MALFORMATION; LYMPHOID ORGAN; MACROPHAGE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 84982980422     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.14471     Document Type: Article

References (32)

1. Vikkula M, Boon LM, Mulliken JB, Olsen BR. Molecular basis of vascular anomalies. Trends Cardiovasc Med 1998; 8:281–92.
2. Lokmic Z, Mitchell GM, Koh Wee Chong N et al. Isolation of human lymphatic malformation endothelial cells, their in vitro characterization and in vivo survival in a mouse xenograft model. Angiogenesis 2014; 17:1–15.
3. Yadav P, De Castro DK, Waner M et al. Vascular anomalies of the head and neck: a review of genetics. Semin Ophthalmol 2013; 28:257–66.
4. Wu JK, Kitajewski C, Reiley M et al. Aberrant lymphatic endothelial progenitors in lymphatic malformation development. PLoS ONE 2015; 10:e0117352.
5. Hogeling M, Adams S, Law J, Wargon O. Lymphatic malformations: clinical course and management in 64 cases. Australas J Dermatol 2011; 52:186–90.
6. Wynn TA, Chawla A, Pollard JW. Macrophage biology in development, homeostasis and disease. Nature 2013; 496:445–55.
7. Stoger JL, Gijbels MJ, van der Velden S et al. Distribution of macrophage polarization markers in human atherosclerosis. Atherosclerosis 2012; 225:461–8.
8. Pechkovsky DV, Prasse A, Kollert F et al. Alternatively activated alveolar macrophages in pulmonary fibrosis – mediator production and intracellular signal transduction. Clin Immunol 2010; 137:89–101.
9. Leal MC, Dabritz J. Immunoregulatory role of myeloid-derived cells in inflammatory bowel disease. Inflamm Bowel Dis 2015; 21:2936–47.
10. D'Alessio S, Correale C, Tacconi C et al. VEGF-C-dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel disease. J Clin Invest 2014; 124:3863–78.
11. Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell 2010; 141:39–51.
12. Hall KL, Volk-Draper LD, Flister MJ, Ran S. New model of macrophage acquisition of the lymphatic endothelial phenotype. PLoS ONE 2012; 7:e31794.
13. Ran S, Montgomery KE. Macrophage-mediated lymphangiogenesis: the emerging role of macrophages as lymphatic endothelial progenitors. Cancers 2012; 4:618–57.
14. Chen G, Zhang W, Li YP et al. Hypoxia-induced autophagy in endothelial cells: a double-edged sword in the progression of infantile haemangioma? Cardiovasc Res 2013; 98:437–48.
15. Sun Y, Jia J, Zhang W et al. A reproducible in vivo model of lymphatic malformation in rats. J Comp Pathol 2011; 145:390–8.
16. Dieu-Nosjean MC, Goc J, Giraldo NA et al. Tertiary lymphoid structures in cancer and beyond. Trends Immunol 2014; 35:571–80.
17. Kirsh AL, Cushing SL, Chen EY et al. Tertiary lymphoid organs in lymphatic malformations. Lymphat Res Biol 2011; 9:85–92.
18. Zheng W, Aspelund A, Alitalo K. Lymphangiogenic factors, mechanisms, and applications. J Clin Invest 2014; 124:878–87.
19. Zhang W, Chen G, Wang FQ et al. Macrophages contribute to the progression of infantile hemangioma by regulating the proliferation and differentiation of hemangioma stem cells. J Invest Dermatol 2015; 135:3163–72.
20. Wang FQ, Chen G, Zhu JY et al. M2-polarised macrophages in infantile haemangiomas: correlation with promoted angiogenesis. J Clin Pathol 2013; 66:1058–64.
21. Ji H, Cao R, Yang Y et al. TNFR1 mediates TNF-α-induced tumour lymphangiogenesis and metastasis by modulating VEGF-C–VEGFR3 signalling. Nat Commun 2014; 5:4944.
22. Owen JL, Mohamadzadeh M. Macrophages and chemokines as mediators of angiogenesis. Front Physiol 2013; 4:159.
23. Ghanta S, Cuzzone DA, Torrisi JS et al. Regulation of inflammation and fibrosis by macrophages in lymphedema. Am J Physiol Heart Circ Physiol 2015; 308:H1065–77.
24. Mounzer RH, Svendsen OS, Baluk P et al. Lymphotoxin-α contributes to lymphangiogenesis. Blood 2010; 116:2173–82.
25. Buckley CD, Barone F, Nayar S et al. Stromal cells in chronic inflammation and tertiary lymphoid organ formation. Annu Rev Immunol 2015; 33:715–45.
26. Ruddle NH. Lymphatic vessels and tertiary lymphoid organs. J Clin Invest 2014; 124:953–9.
27. Shen H, Wang X, Shao Z et al. Alterations of high endothelial venules in primary and metastatic tumors are correlated with lymph node metastasis of oral and pharyngeal carcinoma. Cancer Biol Ther 2014; 15:342–9.
28. Ohya A, Kobayashi M, Sakai Y et al. Lymphocyte recruitment via high endothelial venules in lymphoid stroma of Warthin's tumour. Pathology 2013; 45:150–4.
29. Palframan RT, Jung S, Cheng G et al. Inflammatory chemokine transport and presentation in HEV: a remote control mechanism for monocyte recruitment to lymph nodes in inflamed tissues. J Exp Med 2001; 194:1361–73.
30. Chaudry G, Guevara CJ, Rialon KL et al. Safety and efficacy of bleomycin sclerotherapy for microcystic lymphatic malformation. Cardiovasc Intervent Radiol 2014; 37:1476–81.
31. Bracke KR, Verhamme FM, Seys LJ et al. Role of CXCL13 in cigarette smoke-induced lymphoid follicle formation and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013; 188:343–55.
32. Halle S, Dujardin HC, Bakocevic N et al. Induced bronchus-associated lymphoid tissue serves as a general priming site for T cells and is maintained by dendritic cells. J Exp Med 2009; 206:2593–601.